Clopidogrel and Nintedanib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Nintedanib (nintedanib). Common drug interactions include atrial fibrillation among females and epistaxis among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Nintedanib. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Nintedanib?

Nintedanib has active ingredients of nintedanib. eHealthMe is studying from 1,514 Nintedanib users. Check the latest studies of Nintedanib.

On Jul, 07, 2026

12 people who take Clopidogrel and Nintedanib together, and have interactions are studied.

Clopidogrel and Nintedanib drug interactions.

What are the common drug interactions of Clopidogrel and Nintedanib, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Acute myocardial infarction (acute heart attack)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Respiratory failure (inadequate gas exchange by the respiratory system)

male:

Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Hepatocellular carcinoma (liver cancer)
Idiopathic pulmonary fibrosis (chronic lung disease)
Lung cancer metastatic (lung cancer spreads to other parts)
Pneumomediastinum (air is present in the mediastinum)
Pulmonary embolism (blockage of the main artery of the lung)
Sputum increased
General physical health deterioration (weak health status)
Hypophagia (reduced food intake)

What are the common drug interactions of Clopidogrel and Nintedanib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Colitis ulcerative (inflammation of colon with ulcer)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Lung cancer metastatic (lung cancer spreads to other parts)
Pneumomediastinum (air is present in the mediastinum)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Acute myocardial infarction (acute heart attack)
Dyspnoea (difficult or laboured respiration)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Haemorrhage intracranial (bleeding within the skull)
Hepatocellular carcinoma (liver cancer)
Idiopathic pulmonary fibrosis (chronic lung disease)
Sputum increased
Subdural haemorrhage (bleeding between the skull and the surface of the brain)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 3 people, 25.00%
Interstitial Lung Disease: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Sleep Disorder: 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Gastritis (inflammation of stomach): 2 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Nintedanib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously